Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysis.
Ahmed ElhakeemAmy E TaylorHazel M InskipJonathan Yinhao HuangToby MansellCarina RodriguesFederica AstaSophia M BlaauwendraadSiri Eldevik HåbergJane HallidayMargreet W Harskamp-van GinkelJian-Rong HeVincent W V JaddoeSharon LewisGillian M MaherYannis ManiosFergus P McCarthyIrwin K M ReissFranca RusconiTheodosia SalikaMuriel TaffletXiu QiuBjørn O ÅsvoldDavid P BurgnerJerry K Y ChanLuigi GagliardiRomy GaillardBarbara HeudeMaria Christine MagnusGeorge MoschonisDeirdre MurrayScott McGill NelsonDaniela PortaRichard SafferyHenrique BarrosJohan Gunnar ErikssonTanja G M VrijkotteDeborah A LawlorPublished in: European heart journal (2023)
These findings of small and statistically non-significant differences in offspring cardiometabolic outcomes should reassure people receiving ART. Longer-term follow-up is warranted to investigate changes over adulthood in the risks of hypertension, dyslipidaemia, and preclinical and clinical cardiovascular disease.
Keyphrases
- cardiovascular disease
- gestational age
- blood pressure
- healthcare
- public health
- human health
- preterm infants
- mental health
- type diabetes
- hiv infected
- cell therapy
- adipose tissue
- risk assessment
- antiretroviral therapy
- health promotion
- cardiovascular risk factors
- metabolic syndrome
- coronary artery disease
- insulin resistance
- glycemic control
- data analysis